Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

about

Tau-based therapies in neurodegeneration: opportunities and challenges.

P2860

Q47689697-E4BCA63C-C5D0-40F0-A31F-DA1099EAA1C5

P2860

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

Item

http://www.wikidata.org/entity/Q35854093

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@ast

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@en

type

Item

label

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@ast

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@en

prefLabel

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@ast

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@en

P1476

Neuroprotective effects of Cer ...... nd fronto-temporal tauopathies

@en

P2093

Anthony Adame

http://www.w3.org/2001/XMLSchema#string

Dieter Meier

http://www.w3.org/2001/XMLSchema#string

Hemma Brandstaetter

http://www.w3.org/2001/XMLSchema#string

Jazmin Florio

http://www.w3.org/2001/XMLSchema#string

Michael Mante

http://www.w3.org/2001/XMLSchema#string

Stefan Winter

http://www.w3.org/2001/XMLSchema#string

P2860

Physiological and pathological phosphorylation of tau by Cdk5

Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets

Tau and tauopathies

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

Neurodegenerative tauopathies

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.

Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach.

The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.

P2888

s12868-015-0218-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12868-015-0218-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eliezer Masliah

Edward Rockenstein

Kiren Ubhi

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284771012

http://www.w3.org/2001/XMLSchema#string

P6179

1024417667

http://www.w3.org/2001/XMLSchema#string

P698

26611895

http://www.w3.org/2001/XMLSchema#string

P932

4662012

http://www.w3.org/2001/XMLSchema#string

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

about

P2860

P2860

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932